Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Life. A Gender-sensitive Approach Towards a Comprehensive and Equitable Perspective.

The goal of this observational study is to determine the differences in the prevalence, characteristics and evolution of frailty between men and women diagnosed with MASLD, and to establish its relationship with clinical, functional, hormonal and social parameters.

NCT Number	NCT07652892
Lead Sponsor	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions	Steatosis of Liver
Enrollment	140 participants
Start Date	2026-05-26
Primary Completion	2027-02-25 (estimated)
Study Completion	2028-05-25 (estimated)
Updated on ClinicalTrials.gov	2026-06-17